Skip to Main Content
Alyssa Bouska
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tet2 deficiency alters CD4+ T cell function and promotes T cell lymphoma with a TFH cell immunophenotype

Tayla B. Heavican-Foral, Yuping Li, Waseem Lone, Alyssa Bouska, Jibin Zhang, Ruimeng Yang, Xuxiang Liu, Ab Rauf Shah, Abdul Rouf Mir, Joseph Rohr, Dylan Jochum, Anurag Kumar, Ravneet Singh Chawla, Catalina Amador, Jiayu Yu, Tyler Herek, Jacob Robinson, Chengfeng Bi, Sunandini Sharma, Tyler Gilbreath, R. Katherine Hyde, Timothy W. McKeithan, Chan-Wang Lio, Anjana Rao, Giorgio Inghirami, Joesph Khoury, Wing C. Chan, Javeed Iqbal
Journal: Journal of Experimental Medicine
J Exp Med (2026) 223 (6): e20250194.
https://doi.org/10.1084/jem.20250194
Published: 28 April 2026
View article titled, Tet2 deficiency alters CD4+ T cell function and promotes T cell lymphoma with a TFH cell immunophenotype
Open the PDF for Tet2 deficiency alters CD4+ T cell function and promotes T cell lymphoma with a TFH cell immunophenotype in another window
Includes: Supplementary data
Journal Articles

Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy

Elisa Oricchio, Giovanni Ciriello, Man Jiang, Michael H. Boice, Jonathan H. Schatz, Adriana Heguy, Agnes Viale, Elisa de Stanchina, Julie Teruya-Feldstein, Alyssa Bouska, Tim McKeithan, Chris Sander, Wayne Tam, Venkatraman E. Seshan, Wing-Chung Chan, R.S.K. Chaganti, Hans-Guido Wendel
Journal: Journal of Experimental Medicine
J Exp Med (2014) 211 (7): 1379–1391.
https://doi.org/10.1084/jem.20132120
Published: 09 June 2014
View article titled, Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy
Open the PDF for Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy in another window
Includes: Supplementary data

Advertisement

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal